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Abstract
Background:  Esophageal  stricture  due  to  caustic  ingestion  is  one  of  the  most  difﬁcult  problems
to manage.  Esophageal  dilations  are  the  usual  treatment  and  they  require  a  great  number
of sessions  in  the  majority  of  cases.  This  implies  time,  risks  for  the  patient,  anguish  for  the
relatives,  and  very  often,  frustration  for  the  physician.
Objectives:  To  evaluate  the  efﬁcacy  of  the  application  of  topical  mitomycin  C  and  intralesional
triamcinolone  in  the  prevention  of  post-dilation  esophageal  stricture  recurrence.
Material  and  methods:  A  prospective,  comparative,  nonrandomized,  and  longitudinal  study
was conducted  that  compared  a  cohort  of  16  patients  treated  with  mitomycin  C  (2009-2012)
with a  retrospective  cohort  of  34  patients  treated  with  triamcinolone  (2002-2009).
Results:  The  patients  treated  with  intralesional  triamcinolone  had  a  median  of  11  dilations
(minimum 4  and  maximum  24),  whereas  the  median  in  the  patients  treated  with  topical
mitomycin  C  was  4.5  (minimum  3  and  maximum  8).  The  groups  were  compared  using  the
Mann-Whitney  U  test,  ﬁnding  a  statistically  signiﬁcant  difference  of  a  two-tailed  P  <  .001.
In the  multiple  linear  regression  model,  the  dependent  variable  was  the  number  of  dilations
and the  independent  variables  were  the  type  of  lesion  and  treatment.  The  result  was  an  R2
.676  with  a  signiﬁcance  level  of  P  <  .001,  in  which  the  regression  coefﬁcient  for  treatment  was
B −.682  (95%  CI  −8.286  to  −5.025)  and  the  lesion  grade  was  B  .435  (95%  CI  2.043-4.573).
The ANOVA  result  was  an  F  49.08  and  a  P  <  .001  and  showed  that  the  independent  variables
of type  of  lesion  and  treatment  had  a  linear  relation  with  the  number  of  dilations,  reinforcing
the fact  that  our  results  were  not  due  to  chance.
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Conclusions:  Topical  mitomycin  C  considerably  reduced  the  number  of  esophageal  dilations
compared  with  the  use  of  intralesional  triamcinolone  to  alleviate  dysphagia,  and  therefore  we
suggest it  as  a  treatment  option  in  strictures  due  to  caustic  ingestion.
© 2015  Asociación  Mexicana  de  Gastroenterología.  Published  by  Masson  Doyma  México  S.A.
This is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Mitomicina  C  tópica  contra  triamcinolona  intralesional  en  el  manejo  de  la  estenosis
esofágica  por  cáusticos
Resumen
Antecedentes:  La  estenosis  esofágica  secundaria  a  ingestión  de  cáusticos  es  uno  de  los  proble-
mas de  más  difícil  manejo.  El  tratamiento  habitual  son  las  dilataciones  esofágicas  que  requiere
en la  mayoría  de  los  casos  un  gran  número  de  sesiones,  lo  cual  implica  tiempo,  riesgos  para  el
paciente,  angustia  en  los  familiares  y  en  muchas  ocasiones  frustración  para  el  médico.
Objetivos:  Valorar  la  eﬁcacia  de  la  aplicación  de  mitomicina  C  y  triamcinolona  en  la  prevención
de recurrencia  de  estenosis  esofágica  posdilatación.
Material  y  métodos: Estudio  prospectivo,  comparativo,  no  aleatorizado  y  longitudinal  en  donde
se incluyó  una  cohorte  de  16  pacientes  tratados  con  mitomicina  C  (2009-2012)  y  se  compararon
con una  cohorte  retrospectiva  de  34  pacientes  tratados  con  triamcinolona  (2002-2009).
Resultados:  La  mediana  de  dilataciones  de  los  pacientes  en  los  que  se  utilizó  triamcinolona
intralesional  fue  de  11  (mínimo  4  máximo  24),  mientras  que  los  manejados  con  mitomicina  C
tópica fue  de  4,5  (mínimo  de  3  y  máximo  de  8).  Al  comparar  estos  grupos  con  U  de  Mann-Whitney,
se encontró  que  la  diferencia  es  estadísticamente  signiﬁcativa  a  2  colas  p  <  0.001.
Al realizarse  el  modelo  de  regresión  lineal  múltiple  con  variable  dependiente  el  número  de
dilataciones  y  variables  independientes  tipo  de  lesión  y  tratamiento  se  encontró  una  R2 0.676
con un  nivel  de  signiﬁcación  p  <  0.001,  en  donde  el  coeﬁciente  de  regresión  para  tratamiento
fue ≡  --0.682  (IC  del  95%,  --8.286  a  --5.025)  y  el  de  grado  lesión  fue  ≡  0.435  (IC  del  95%,  2.043-
4.573).
Anova con  una  F  49.08  con  una  p  <  0.001,  lo  que  demuestra  que  las  variables  independientes
tipo de  lesión  y  tratamiento  observan  una  relación  lineal  con  el  número  de  dilataciones,  lo  que
refuerza  que  nuestros  resultados  no  son  debidos  al  azar.
Conclusiones:  La  mitomicina  C  tópica  redujo  considerablemente  el  número  de  dilataciones
esofágicas  en  comparación  al  uso  de  triamcinolona  intralesional  para  aliviar  la  disfagia,  por
lo que  la  sugerimos  como  una  opción  en  el  tratamiento  de  las  estenosis  por  cáusticos.
© 2015  Asociación  Mexicana  de  Gastroenterología.  Publicado  por  Masson  Doyma  México  S.A.
Este es  un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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One  of  the  main  complications  of  the  ingestion  of  caus-
tic  substances  is  esophageal  stricture.  The  management  of
these  problems  is  a  difﬁcult  and  distressing  challenge  for  the
patient,  the  parents,  and  for  the  physician  in  charge  of
the  treatment.  Esophageal  rehabilitation  has  been  carried
out  for  many  years  with  different  techniques,  depending  on
the  experience  of  each  physician.1 Esophageal  prostheses
or  splints,  dilations  with  balloons  or  Savary-Gilliard  plugs,
Hurst  dilators,  etc.,  have  been  used,  but  in  reality,  there  is
no  worldwide  standardization  for  the  management  of  these
patients  and  even  less  so  for  the  use  of  certain  substances
such  as  triamcinolone  acetonide  applied  intralesionally,  or
more  recently,  topical  mitomycin  C.1,2 Triamcinolone  ace-
tonide  is  a  synthetic  corticosteroid  with  a  preventive  effect
on  collagen  synthesis,  ﬁbrosis,  and  chronic  cicatrization  that
A
sas  been  used  for  many  years,  applied  in  intralesional  injec-
ion  after  esophageal  dilations  for  the  purpose  of  delaying
icatrization  and  thus  reducing  the  number  of  dilations.2
itomycin  C  is  an  antineoplastic  and  antiproliferative  agent
hat  reduces  the  formation  of  collagen  through  ﬁbroblasts
nd  impedes  cell  duplication.  It  can  delay  the  cicatrization
rocess  in  certain  tissues,  which  is  why  it  has  been  used  top-
cally  for  treating  esophageal  stricture.3,4 The  main  aim  of
his  study  was  to  evaluate  the  number  of  esophageal  dila-
ions  required  to  achieve  clinical  improvement  in  a  group
f  patients  treated  with  mitomycin  C  and  another
roup  treated  with  triamcinolone  acetonide.
ethods prospective,  comparative,  nonrandomized,  longitudinal
tudy  was  conducted  that  included  a  cohort  of  16  patients
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Table  1  Classiﬁcation  of  caustic  esophagitis  (Maratka).
Grade  I  Hyperemia  and  edema
Grade  II  Yellow  or  white  plaques  with
pseudomembrane  formation
II a  Lesions  located  on  one-third  of  the
esophagus  and  a  single  wall
II b  Concentric  lesions  located  on  one-third  of
the esophagus
II c  Linear  or  concentric  lesions  in  2  or  3  thirds
of the  esophagus
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Figure  1  Punctiform  esophageal  stricture  and  passage  of
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tGrade  III Bleeding  and  ulcerated  mucosa  with  a  thick
exudate
reated  with  mitomycin  C  (2009-2012)  and  they  were  com-
ared  with  a  retrospective  cohort  of  34  patients  treated  with
riamcinolone  (2002-2009).  The  50  patients  were  attended
o  at  the  zone  6,  66,  and  35  hospitals  of  the  Instituto  Mexi-
ano  del  Seguro  Social  in  Ciudad  Juárez,  Chihuahua,  Mexico.
hey  were  diagnosed  with  esophageal  stricture  secondary  to
austic  ingestion  and  managed  with  esophageal  dilations.
Written  statements  of  informed  consent  were  obtained
rom  the  parents  of  the  patients.
In  the  ﬁrst  24  h  after  caustic  ingestion,  upper  endoscopy
as  done  to  classify  the  esophageal  lesion  grade  according
o  the  modiﬁed  Maratka  classiﬁcation5,6 (Table  1).
Four  weeks  after  the  ﬁrst  endoscopy,  a  barium  esopha-
ogram  and  endoscopy  were  carried  out,  establishing  the
iagnosis  of  esophageal  stricture.
All  the  patients  included  in  the  dilation  protocol  pre-
ented  with  some  grade  of  dysphagia  that  was  classiﬁed
ccording  to  the  Mellow  and  Pinkas  scale7 (Table  2).  Because
he  cohort  was  a  pediatric  one  and  the  majority  of  the  chil-
ren  were  preschoolers,  the  dysphagia  was  evaluated  by  the
arents,  and  classiﬁed  as  grade  0:  no  difﬁculty  in  swallow-
ng  foods,  grade  1:  difﬁculty  in  swallowing  solids  (pieces
f  food),  grade  2:  difﬁculty  in  swallowing  soft  solids  (baby
ood),  grade  3:  difﬁculty  in  swallowing  any  type  of  solid  or
iquid,  and  grade  4:  difﬁculty  in  swallowing  saliva  (important
ialorrhea).
rocedure
ll  the  esophageal  dilations  were  carried  out  with  the
atient  under  general  anesthesia,  always  administered  by
 certiﬁed  pediatric  anesthesiologist.  The  dilations  were
erformed  with  Savary-Gilliard  plugs  (ﬂexible  and  directed
lastic  dilators),  ﬁrst  passing  a  ﬂexible  metallic  guidewire
hrough  the  stricture  until  reaching  the  stomach  and  then
assing  a  different  caliber  Savary  dilator,  depending  on  the
Table  2  Dysphagia  scale  (Mellow  and  Pinkas).
Grades  of  dysphagia  Type  of  dysphagia
Grade  0  No  dysphagia
Grade  1  Dysphagia  to  solids
Grade  2  Dysphagia  to  soft  solids
Grade  3  Dysphagia  to  solids  and  liquids
Grade  4  Cannot  even  swallow  saliva
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1he ﬂexible  guidewire  through  the  stricture  until  reaching  the
tomach.
iameter  of  the  stricture,  through  that  same  space  (Fig.  1).
fter  the  dilations,  we  applied  intralesional  triamcinolone  in
 quadrants.  The  steroid  was  applied  in  the  ﬁrst  5  dilations
ith  an  interval  of  one  week  between  the  ﬁrst  and  second
ilation  and  then  every  2  weeks  or  more,  depending  on  the
linical  and  endoscopic  response.
In  the  mitomycin  C  group,  the  same  dilation  technique
as  followed,  after  which  the  medication  was  applied  top-
cally  in  the  ﬁrst  5  dilations  with  an  interval  of  one  week
etween  the  ﬁrst  and  second  dilation  and  then  every  2  weeks
r  more,  depending  on  the  clinical  and  endoscopic  result.
All  the  patients  were  managed  with  prophylactic  oral  ran-
tidine,  begun  after  the  ﬁrst  dilation  and  not  suspended  until
he  treatment  was  ﬁnished.
The  absence  of  dysphagia  for  6  months  after  the  last
ilation  was  considered  good  treatment  response.
All  the  patients  had  follow-up  of  at  least  one  year  after
eing  released  from  the  hospital.
nstruments  utilized
avary-Gilliard  dilators  of  different  diameters  or  French
izes  were  used  (Fig.  2).
A  Pentax  endoscope  of  7.8  mm  in  diameter  was  used
or  the  ﬁrst  diagnostic  endoscopy,  the  esophageal  dila-
ions,  and  the  application  of  intralesional  triamcinolone
cetonide.
A  Pentax  endoscope  of  9.0  mm  in  diameter  and  an  operat-
ng  channel  of  2.8  mm  was  used  for  mitomycin  C  application.
A  Dormia  basket  and  cotton  swab  were  used  for  irrigation
Fig.  3).
escription  of  the  technique
ntralesional  triamcinolone  acetonide  application:.  Esophageal  dilation  under  general  anesthesia  with  a
Pentax  7.8  mm  ﬂexible  endoscope  and  Savary-Gilliard
dilators.
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Figure  4  Pentax  9  mm  endoscope  with  2.8  mm  operating
channel  through  which  the  Dormia  basket  with  cotton  swab  on
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nFigure  2  Savary-Gilliard  dilators.
2.  After  esophageal  dilation  the  Pentax  7.8  mm  ﬂexible
endoscope  was  introduced  and  a  sclerotherapy  needle
was  passed  through  the  operating  channel  to  apply  the
triamcinolone  acetonide  intralesionally  at  a  concentra-
tion  of  40  mg/ml  (1  ml  of  the  steroid  was  diluted  in  3  ml
of  sterile  water).  Always  under  direct  vision,  0.5  ml  to
1  ml  was  applied  per  quadrant  in  the  dilated  area.
Topical  application  of  mitomycin
1.  Esophageal  dilation  under  general  anesthesia  with  Pentax
7.8  mm  ﬂexible  endoscope  and  Savary-Gilliard  dilators.
2.  After  esophageal  dilation  the  Pentax  9.0  mm  ﬂexi-
ble  endoscope  with  a  2.8  mm  operating  channel  was
introduced,  through  which  a  Dormia  basket  with  a  small
cotton  swab  at  its  tip  was  passed  (Fig.  4).
3.  Once  the  dilated  area  was  located,  the  Dormia  basket
irrigator  saturated  the  cotton  swab  with  2  cc  of  mito-
mycin  C  at  a  concentration  of  0.4  mg/ml.  Pressure  was
placed  on  the  eroded  mucosa  with  the  swab,  thus  topi-
cally  applying  the  mitomycin  C  for  3  min,  always  under
direct  vision  (Fig.  5).
Figure  3  Dormia  basket  with  irrigation  channel  and  cotton
swab at  the  tip.
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che tip  passes.
Diagnosis  and  management  of  all  the  patients  were  car-
ied  out  by  the  same  pediatric  gastroenterologist.
tatistical analysis
he  SPSS  16  statistical  package  was  utilized.  Descriptive
tatistics  were  applied  using  measures  of  central  tendency
nd  dispersion  and  normality  tests  for  the  quantitative  varia-
les  and  frequencies,  and  percentages  for  the  categorical
ariables.  The  group  comparisons  were  performed  with  the
ann-Whitney  U  test  because  the  distribution  was  not  nor-
al.  Multiple  linear  regression  was  carried  out  with  the
umber  of  dilations  as  the  dependent  variable,  and  the
ype  of  lesion  and  type  of  treatment  as  the  independent
ariables.
igure  5  Cotton  swab  saturated  with  mitomycin  C  and  topi-
ally applied  to  the  dilated  area.
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Table  3  Patients  with  caustic  stricture  and  application  of
intralesional  triamcinolone.
Age
(months)
Sex  Lesion
classiﬁcation
Dysphagia
grade
Number  of
dilations
27  M  II  b  3  14
11 F  II  b  2  9
23 F  III  4  24  (3)a
18  F  II  b  3  10
36 M  II  b  1  7
26 M  II  b  1  12
22 F  II  b 1  6
28 M  II  b 2  8
27 F  II  b 2  9
19 F  II  b  1  14
17 F  II  c  1  11
20 M  II  b  1  4
22 F  III  3  20  (2)b
28  M  II  b  2  12
18 F  II  c  3  17
148 M  II  b  2  9
14 M  II  c  3  14
32 M  II  c  4  16  (2)b
31  F  II  b  2  10
48 F  II  b  3  12
56 M  II  b  3  15
22 F  II  b  3  12
12 M  II  b  2  10
14 F  II  c  2  9
19 F  II  b  1  11
28 M  II  b  1  12
32 M  II  b  2  8
17 F  II  b  2  14
12 M  II  c 1  11
27 M  II  b  1  9
30 M  II  c 3  15
24 F  II  b 3  11
26 M  II  b  1  12
22 F  II  b  1  10
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Table  4  Patients  with  caustic  stricture  and  application  of
topical  mitomycin  C.
Age
(months)
Sex  Lesion
classiﬁcation
Dysphagia
grade
Number  of
dilations
36  M  II  b  1  4
22 M  II  b  3  7
18 F  II  b  1  5
28 M  II  b  3  8  (2)a
27  F  II  c  1  4
31 F  II  b  2  3
38 F  II  b  1  4
27 M  II  b  2  5
20 F  II  b 1  5
19 M  III  3  7  (2)a
32  M  II  b  2  4
24 F  II  b  2  5
22 M  II  b  1  3
23 M  II  b  1  4
19 F  II  b  1  4
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Diagnostic  endoscopy  at  the  ﬁrst  24  h  after  the  accidentPatient with 3 esophageal strictures at the time of diagnosis.
b Patient with 2 esophageal strictures at the time of diagnosis.
esults
istribution  by  sex  was  24  females  (48%)  and  26  males  (52%).
he  median  age  was  24  months  (minimum  11,  maximum  148
onths).  The  clinical  ﬁndings  and  number  of  dilations  are
hown  in  Tables  3  and  4.
Alkalis  were  the  cause  of  the  lesion  in  46  (92%)  cases  and
cids  were  the  cause  in  4  (8%).
At  the  time  of  initial  diagnosis,  4  patients  had  2
sophageal  stricture  sites  and  one  case  had  3  sites.
The  results  of  the  Kolmogorov-Smirnov  and  Shapiro-Wilk
ormality  tests  for  the  variables  of  age,  dysphagia,  and  num-
er  of  dilations,  grouped  according  to  treatment,  showed
hat  age  in  the  mitomycin  group  was  the  only  variable  with
ormal  distribution.There  were  no  statistically  signiﬁcant  differences  in  the
roup  comparison  using  the  Mann-Whitney  U  test  in  relation
o  age,  sex,  or  dysphagia.
i
m
s31 M  II  c  3  6
a Patients with 2 esophageal strictures at the time of diagnosis.
The  median  of  dilations  in  the  patients  treated  with
ntralesional  triamcinolone  was  11  (minimum  4,  maximum
4),  whereas  it  was  4.5  (minimum  3,  maximum  8)  in  those
anaged  with  topical  mitomycin  C.  In  the  Mann-Whitney  U
est  group  comparison,  there  was  a  statistically  signiﬁcant
ifference  of  a  two-tailed  p  <  0.001.
In  regard  to  lesion  classiﬁcation,  the  patients  with  a  grade
Ic  and  III  were  the  ones  that  in  general  required  a  greater
umber  of  dilations  (Tables  3  and  4).
In  the  multiple  linear  regression  model,  in  which  the
ependent  variable  was  the  number  of  dilations,  and
he  independent  variables  were  the  type  of  lesion  and  treat-
ent,  the  result  was  R2 0.676,  with  a  signiﬁcant  level  of
 < 0.001.  The  regression  coefﬁcient  for  treatment  was  B
0.682  (95%  CI  −8.286  to  −5.025)  and  the  lesion  grade  was
 0.435  (95%  CI  2.043-4.573).
The  ANOVA  result  was  an  F  49.08  and  a  p <  0.001  and
howed  that  the  independent  variables  of  type  of  lesion
nd  treatment  had  a  linear  relation  with  the  number  of  dila-
ions,  reinforcing  the  fact  that  our  results  were  not  due  to
hance.
All  the  patients  had  a  favorable  treatment  response,
eﬁned  as  the  absence  of  dysphagia  and  endoscopic
mprovement  for  at  least  6  months  after  the  last  dilation.
No  secondary  effects  were  reported  with  the  use  of
ntralesional  triamcinolone  or  topical  mitomycin  C.
iscussion
austic  ingestion  continues  to  be  a  pediatric  health  problem
nd  the  group  at  greatest  risk  are  children  under  5  years  of
ge,  with  no  sex-related  predominance,  concurring  with  our
esults.8,9s  a  subject  of  debate,  given  that  some  authors  recom-
end  it  only  if  the  patient  presents  with  some  kind  of
ymptomatology  after  the  caustic  ingestion.10,11 In  our  study,
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this  diagnostic  procedure  was  performed  in  all  the  patients
because  there  was  no  direct  correlation  in  a  large  number  of
patients  between  the  clinical  ﬁndings  related  to  the  buccal
mucosa  and  the  grade  of  the  esophageal  lesion.  There-
fore,  we  felt  it  was  important  to  classify  the  lesion  and  in
this  manner  begin  patient  management,  whether  with  the
patient  hospitalized,  watching  for  possible  complications,  or
releasing  him  or  her  without  treatment  or  with  outpatient
treatment.12,13
Different  therapeutic  modalities  have  been  used  in  an
attempt  to  prevent  post-caustic  ingestion  complications,
such  as  the  use  of  antibiotics,  systemic  corticosteroids,  total
parenteral  nutrition,  nasogastric  tubes,  anti-acids,  splint
placement,  etc.  However,  none  of  them  have  been  shown
to  be  truly  effective.14 In  our  work,  we  always  used  antibi-
otics  and  systemic  steroids,  depending  on  the  grade  of
the  esophageal  lesion.  Nevertheless,  as  in  the  majority
of  the  studies  published,  complications  were  almost  always
present.
In  the  present  study,  we  observed  that  the  patients  that
developed  esophageal  stricture,  all  had  at  least  a  IIb  lesion.
This  problem  was  not  found  in  the  patients  that  had  I or  IIa
lesions.  The  patients  that  were  the  most  difﬁcult  to  man-
age  in  relation  to  the  number  of  dilations  were  those  with  a
grade  III  lesion  with  the  Maratka  classiﬁcation.  In  our  liter-
ature  review  we  found  no  study  relating  esophageal  lesion
grade  according  to  the  Maratka  classiﬁcation  with  the  pres-
ence  of  stricture.
When  the  patient  presents  with  dysphagia,  ﬁrst  an  esoph-
agogram  is  done  to  evaluate  the  type  of  stricture,  its
location,  number,  length,  etc.  In  this  manner  we  can  plan
the  commencement  of  dilations,  performing  them  under  ﬂu-
oroscopy  when  the  strictures  are  complex.15
We  administer  a  prophylactic  acid  secretion  inhibitor,
such  as  ranitidine,  to  all  patients  that  undergo  an  esophageal
dilation  program,  given  that  these  patients  can  present
with  gastroesophageal  reﬂux  due  to  esophageal  motility
alterations  secondary  to  the  burn,  or  present  with  short
esophagus.1,14
Of  the  50  patients  with  esophageal  stricture,  we  observed
that  5  of  them  had  more  than  one  stricture  at  the  time  of
diagnosis  and  they  were  the  patients  that  required  more
dilation  sessions.
The  majority  of  patients  had  short  strictures,  but  it  was
not  possible  to  obtain  that  datum  in  all  the  patients,  and  so
it  was  not  included  in  the  analysis.
Initial  management  of  esophageal  stricture  continues  to
be  based  primarily  on  esophageal  dilations.  In  some  cases
the  post-dilation  use  of  substances  such  as  triamcinolone
acetonide  and  mitomycin  C  has  been  employed  in  an  attempt
to  reduce  the  length  of  time  of  treatment.15
Triamcinolone  acetonide  is  a  synthetic  corticosteroid  that
has  been  used  in  topical,  oral,  or  inhaled  forms,  or  as  intra-
articular  or  intramuscular  injection  as  treatment  in  diverse
pathologies  with  important  inﬂammatory  processes.  It  has
been  applied  for  many  years  in  patients  with  esophageal
stricture,  as  an  intralesional  injection  after  the  esophageal
dilations,  for  the  purpose  of  delaying  cicatrization.  How-
ever,  contradictory  study  results  have  been  published.14
In  our  experience,  we  had  moderate  results  with  its  use,
given  that  the  mean  of  dilations  per  patient  was  practically
12  sessions,  signifying  a  treatment  time  of  up  to  2  years.
D
f
tnagement  of  esophageal  stricture  253
Mitomycin  C  is  an  antibiotic  derived  from  Streptomyces
aespitosus.  It  is  an  antineoplastic  and  antiproliferative
gent  that  has  been  used  in  different  specialities,  including
ncology,  ophthalmology,  otorhinolaryngology,  and  recently
n  patients  with  esophageal  stricture.15 Its  use  in  the  latter
athology  varies  from  article  to  article,  but  the  large  major-
ty  state  that  it  is  applied  topically  with  gauzes  or  cotton
wabs  impregnated  with  the  substance.  Others  report  its  use
ith  sprayers  or  applied  through  rigid  or  ﬂexible  esophago-
copes  at  the  tip  of  the  hood,  to  avoid  contact  of  the
ubstance  with  healthy  mucosa.1,12,15 In  an  effort  to  ﬁnd  a
ore  practical  technique  and  preventing  as  much  as  possible
he  contact  of  mitomycin  C  with  healthy  mucosa,  we  devel-
ped  a  new  application  technique.  We  apply  the  substance
y  means  of  a  Dormia  basket  and  have  had  good  results,  con-
urring  with  the  majority  of  articles  in  which  its  topical  use
as  importantly  reduced  the  number  of  dilations  in  patients
ith  difﬁcult-to-manage  esophageal  strictures.  There  is  no
niform  consensus  on  the  number  of  applications  of  these
edications,  given  that  the  published  articles  describe  1  to
2  applications  per  patient.1,15 In  our  7-year  experience,  we
ave  used  triamcinolone  acetonide  in  the  ﬁrst  5  dilations  of
ach  patient  with  different  clinical  responses.  Due  to  the
oor  response  of  some  patients  to  the  use  of  the  intrale-
ional  steroid,  in  2009  we  decided  to  use  topical  mitomycin
 during  the  ﬁrst  5  dilations  of  each  patient  and  compare
ts  use  with  that  of  the  steroid.  We  found  that  the  num-
er  of  sessions  decreased  signiﬁcantly  with  mitomycin  C.
oncentrations  of  mitomycin  C  have  been  used  from  0.1  mg
p  to  1  mg/ml.1,15 In  our  patients  we  used  a  concentra-
ion  of  0.4  mg/ml,  as  in  the  majority  of  the  studies,  with
ood  results,  and  we  found  no  secondary  effects  with  its
se.
Even  though  the  results  showed  a  clear  statistical  differ-
nce  in  favor  of  mitomycin  C,  our  study  has  the  limitation
hat  the  cohort  was  compared  with  a  retrospective  one  and
here  was  no  randomizing.  This  paves  the  way  for  conducting
 future  randomized,  comparative,  and  prospective  study
linded  to  the  evaluator  to  be  able  to  arrive  at  deﬁnitive
onclusions.
onclusions
t  is  difﬁcult  to  develop  the  protocol  of  a  study  on  caus-
ic  ingestion  and  even  more  so  on  its  complications,  given
hat  all  patients  do  not  ingest  the  same  substance,  the  same
oncentration,  nor  is  it  in  contact  with  the  mucosa  for  the
ame  length  of  time.  Nevertheless,  in  accordance  with  our
tudy  results,  we  suggest  the  use  of  mitomycin  C  as  an  alter-
ative  in  the  management  of  patients  with  difﬁcult-to-treat
sophageal  stricture  due  to  caustic  ingestion.
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